EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach

Alberto Montolío iD, José Cegoñino iD, Elena Garcia-Martin iD, Amaya Pérez Del Palomar iD

Acta Ophthalmologica · 2024-05 · 102 (3)

DOI: 10.1111/aos.15722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, online erschienen am 10.06.2023. Verfasst von Alberto Montolío und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterials Group, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain. Hauptthemen laut MEDLINE: Multiple Sclerosis, Deep Learning. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, Ministerio de Economía y Competitividad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The macular ganglion cell layer (mGCL) is a strong potential biomarker of axonal degeneration in multiple sclerosis (MS). For this reason, this study aims to develop a computer‐aided method to facilitate diagnosis and prognosis in MS.

Methods

This paper combines a cross‐sectional study of 72 MS patients and 30 healthy control subjects for diagnosis and a 10‐year longitudinal study of the same MS patients for the prediction of disability progression, during which the mGCL was measured using optical coherence tomography (OCT). Deep neural networks were used as an automatic classifier.

Results

For MS diagnosis, greatest accuracy (90.3%) was achieved using 17 features as inputs. The neural network architecture comprised the input layer, two hidden layers and the output layer with softmax activation. For the prediction of disability progression 8 years later, accuracy of 81.9% was achieved with a neural network comprising two hidden layers and 400 epochs.

Conclusion

We present evidence that by applying deep learning techniques to clinical and mGCL thickness data it is possible to identify MS and predict the course of the disease. This approach potentially constitutes a non‐invasive, low‐cost, easy‐to‐implement and effective method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisDeep LearningHumansRetinal Ganglion CellsCross-Sectional StudiesLongitudinal StudiesRetinaPrognosisBiomarkersTomography, Optical Coherence

Stichwörter der Autor:innen

deep learningmultiple sclerosisoptical coherence tomographyretinal ganglion cell layer

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Biomaterials Group, Aragon Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.
  • Mechanical Engineering Department, University of Zaragoza, Zaragoza, Spain.
  • Ophthalmology Department, Miguel Servet University Hospital, Zaragoza, Spain.
  • GIMSO Research and Innovation Group, Aragon Institute for Health Research (IIS Aragon), Zaragoza, Spain.

ORCID-Profile: Alberto Montolío, José Cegoñino, Elena Garcia-Martin, Amaya Pérez Del Palomar

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Ciencia, Innovación y Universidades
  • Ministerio de Economía y Competitividad

Zitieren

APA

Montolío, A., Cegoñino, J., Garcia-Martin, E., & Pérez Del Palomar, A. (2024). The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach. Acta Ophthalmologica, 102(3). https://doi.org/10.1111/aos.15722

Vancouver

Montolío A, Cegoñino J, Garcia-Martin E, Pérez Del Palomar A. The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach. Acta Ophthalmologica. 2024;102(3). doi:10.1111/aos.15722

BibTeX
@article{Montolo2024,
  author = {Montolío, Alberto and Cegoñino, José and Garcia-Martin, Elena and Pérez Del Palomar, Amaya},
  title = {The macular retinal ganglion cell layer as a biomarker for diagnosis and prognosis in multiple sclerosis: A deep learning approach},
  journal = {Acta Ophthalmologica},
  year = {2024},
  volume = {102},
  number = {3},
  doi = {10.1111/aos.15722}
}
Kostenlos starten →